RadNet Stock (NASDAQ:RDNT)
Previous Close
$59.29
52W Range
$45.00 - $93.65
50D Avg
$54.56
200D Avg
$63.58
Market Cap
$4.34B
Avg Vol (3M)
$798.39K
Beta
1.44
Div Yield
-
RDNT Company Profile
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
RDNT Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|
| Commercial Insurance1 | $1.02B | $897.95M | $785.13M |
| Health Care, Other | $46.72M | $20.11M | $19.43M |
| Health Care, Management Service | $24.68M | $17.94M | $22.23M |
| Workers' Compensation/Personal Injury1 | $43.67M | $47.36M | $51.34M |
| Medicaid1 | $44.74M | $43.17M | $38.28M |
| Medicare1 | $410.07M | $363.86M | $311.12M |
| Capitation Arrangements | $136.57M | $153.43M | $152.04M |
| Health Care, Patient Service Other | - | $42.25M | $31.85M |
| Software and Teleradiology | - | $18.08M | $14.24M |
Fiscal year ends in Dec 24 | Currency in USD